Page last updated: 2024-08-21

pyrazines and enalaprilat anhydrous

pyrazines has been researched along with enalaprilat anhydrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Billings, FT; Brown, NJ; Devin, JK; Nian, H; Pretorius, M; Yu, C	1

Trials

1 trial(s) available for pyrazines and enalaprilat anhydrous

Article	Year
Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:5 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cross-Over Studies; Dipeptidyl Peptidase 4; Double-Blind Method; Enalaprilat; Enzyme Inhibitors; Female; Heart Rate; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Peptidyl-Dipeptidase A; Pyrazines; Sitagliptin Phosphate; Substance P; Sympathetic Nervous System; Triazoles; Vascular Resistance	2014

Article

Year

Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.

Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:5

Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cross-Over Studies; Dipeptidyl Peptidase 4; Double-Blind Method; Enalaprilat; Enzyme Inhibitors; Female; Heart Rate; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Peptidyl-Dipeptidase A; Pyrazines; Sitagliptin Phosphate; Substance P; Sympathetic Nervous System; Triazoles; Vascular Resistance

2014